A new study has discovered a chemical compound, which has shown antiviral activity that can help treat Zika virus. This class of compounds is believed to treat respiratory syncytial virus (RSV).
Respiratory Syncytial Virus is an infection of the respiratory tract and the lungs. It mostly affects young children and could lead to death.
“This is both a remarkable scientific discovery and also something that has the potential to positively affect not only global health but also the economy of Canada,” said Fred West, the professor who led the study in the Department of chemistry.
The compound found for this study is similar to isatisine A—an antiviral compound found in traditional Chinese herbal medicine. For the study, the team tested this compound against RSV and Zika virus.
The results were positive and showed active and effective against both viral infections. The study was publsihed in the Journal of Organic Chemistry.
Zika virus is a mosquito-borne disease that spreads through the bite of a mosquito carrying the virus. It is transmitted by the mosquito responsible for yellow fever, chikungunya and dengue. The incubation period of the disease has not been defined but it is believed to be a couple of days. Some of the symptoms of Zika virus are: